Evaluation of the Migraine Treatment Sumatriptan/Naproxen Sodium on Blood Pressure Following Long-Term Administration

Journal of Clinical Hypertension

Volumn 13, Issue 12, 2011, Pages 910-916

  White, William B ^a   Derosier, Frederick J ^b   Thompson, April H ^b   Adams, Bryan E ^b   Goodman, David K ^b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NAPROXEN; SUMATRIPTAN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONFIDENCE INTERVAL; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MIGRAINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD PRESSURE; CONFIDENCE INTERVALS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HEALTH STATUS INDICATORS; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIGRAINE DISORDERS; NAPROXEN; RISK FACTORS; SEROTONIN RECEPTOR AGONISTS; SUMATRIPTAN; TIME FACTORS;

EID: 83055176317     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2011.00554.x     Document Type: Article

References (19)

1. Cleves C, Tepper SJ. Sumatriptan/naproxen sodium combination for the treatment of migraine. Expert Rev Neurother. 2008;8:1289-1297.
2. Brandes JL, Kudrow D, Stark SR, et al. Sumatriptan-naproxen for acute treatment of migraine. JAMA. 2007;297:1443-1454.
3. Winner P, Cady RK, Ruoff GE, et al. Twelve-month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migraine. Mayo Clin Proc. 2007;82:61-68.
4. Fowler PA, Lacey LF, Thomas M, et al. The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan. Eur Neurol. 1991;31:291-294.
5. Imitrex (sumatriptan tablets) prescribing information. GlaxoSmithKline, Research Triangle Park, NC. February 2010.
6. Antman EM, Bennett JS, Daugherty A, et al. Use of nonsteroidal anti-inflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation. 2007;115:1634-1642.
7. Treximet (sumatriptan and naproxen sodium) prescribing information. GlaxoSmithKline, Research Triangle Park, NC. December 2009. Accessed at 18Sept2011.
8. Haberer LJ, Walls CM, Lener SE, et al. Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine. Headache. 2010;50:357-373.
9. Headache Classification Committee of the International Headache Society. The international classification of headache disorders, 2nd ed. Cephalalgia. 2004;1:9-160.
10. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
11. Morton V, Torgerson DJ. Regression to the mean: treatment effect without the intervention. J Eval Clin Pract. 2005;11:59-65.
12. White WB, Mehrotra DV, Black HR, et al. Effects of controlled-onset extended-release verapamil on nocturnal blood pressure (dippers vs nondippers). COER-Verapamil Study Group. Am J Cardiol. 1997;80:469-474.
13. Denolle T, Waeber B, Kieldsen S, et al. Self-measurement of blood pressure in clinical trials and therapeutic applications. Blood Press Monit. 2000;5:145-149.
14. Pickering TG, White WB. ASH position paper. When and how to use self (home) and ambulatory blood pressure monitoring. J Clin Hypertens. 2008;10:850-855.
15. Baquet JP, Mallion JM. Self-monitoring of blood pressure should be used in clinical trials. Blood Press Monit. 2002;7:55-59.
16. White WB, Salzman P, Schwid SR, et al. Transtelephonic home blood pressure to assess the monoamine oxidase-B inhibitor rasagiline in Parkinson disease. Hypertension. 2008;52:587-593.
17. Diamond S, Bigal ME, Silberstein S, et al. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention Study. Headache. 2007;47:355-363.
18. Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol. 2008;7:354-361.
19. Winner P, Cady RK, Ruoff GE, et al. Twelve-month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migraine. Mayo Clin Proc. 2007;82:61-68.